Studies on optimizing in vitro transdermal permeation of ondansetron hydrochloride using nerodilol, carvone, and limonene as penetration enhancers

Pharmaceutical Development and Technology

Volumn 13, Issue 3, 2008, Pages 177-185

  Krishnaiah, Yellela S R ^a   Raju, Vengaladasu ^b   Shiva Kumar, Mantri ^b   Rama, Bukka ^b   Raghumurthy, Vanambattina ^b   Ramana Murthy, Kolapalli V ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b ANDHRA UNIVERSITY   (India)

Author keywords

Carvone; In vitro permeation; Limonene; Nerodilol; Ondansetron; Transdermal

Indexed keywords

ALCOHOL; CARVONE; HYDROXYPROPYLCELLULOSE; LIMONENE; NERODILOL; ONDANSETRON; PENETRATION ENHANCING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG PENETRATION; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MALE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIEMETICS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXENES; EPIDERMIS; EXCIPIENTS; GELS; MALE; MONOTERPENES; ONDANSETRON; RATS; SKIN ABSORPTION; TERPENES;

EID: 45849091873     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450801949350     Document Type: Article

References (34)

1. Markham A, Sorkin EM. Ondansetron: an update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs. 1993;45:931-952.
2. Bozigian HP, Pritchard JF, Gooding AE, Pakes GE. Ondansetron absorption in adults: effect of dosage form, food, and antacids. J. Pharm. Sci. 1994;83:1011-1013.
3. Hsyu PH, Pritchard JF, Bozigian HP, et al. Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum. Pharm. Res. 1994;11:156-159.
4. Hussain AA, Dakkuri A, Itoh S. Nasal absorption of ondansetron in rats: an alternative route of drug delivery. Cancer Chemother. Pharmacol. 2000;45:432-434.
5. Bronaugh RL, Maibach HIE. Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery. 2nd ed. New York: Marcel Dekker; 1989.
6. Williams AC, Barry BW. Penetration enhancers. Adv. Drug Deliv. Rev. 2004;56:603-618.
7. Gao S, Singh J. In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes. J. Control. Release. 1998;51:193-199.
8. Zhao K, Singh J. Mechanism of percutaneous absorption of tamoxifen by terpenes: eugenol, D-limonene and menthone. J. Control. Release. 1998;55:253-260.
9. Zhao K, Singh J. In vitro percutaneous absorption of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J. Control. Release. 1999;62:359-366.
10. El-Kattan AF, Asbill CS, Kim N, Michniak BB. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 2001;215:229-240.
11. Takahashi K, Rytting JH. Novel approach to improve permeation of ondansetron across shed snake skin as a model membrane. J. Pharm. Pharmacol. 2001;53:789-794.
12. Dimas DA, Dallas PP, Rekkas DM. Ion pair formation as a possible mechanism for the enhancement effect of lauric acid on the transdermal permeation of ondansetron. Pharm. Dev. Technol. 2004;9:311-320.
13. Dimas DA, Dallas PP, Rekkas DM. Use of an 8(1)3(2) asymmetrical factorial design for the in vitro evaluation of ondansetron permeation through human epidermis. Pharm. Dev. Technol. 2004;9:39-48.
14. Gwak HS, Oh IS, Chun IK. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers. Drug Dev. Ind. Pharm. 2004;30:187-194.
15. Gwak HS, Oh IS, Chun IK. In vitro percutaneous absorption of ondansetron hydrochloride from pressure-sensitive adhesive matrices through hairless mouse skin. Arch. Pharm. Res. 2003;26:644-648.
16. Krishnaiah YSR, Shiva Kumar M, Raju V, Lakshmi M, Rama B. Penetration enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron hydrochloride across rat epidermis. Drug Dev. Ind. Pharm. In press.
17. Keshary PR, Chien YW. Mechanism of transdermal controlled nitroglycerin administration. Part 2. Assessment of rate controlling steps. Drug Dev. Ind. Pharm. 1984;10:1663-1699.
18. Michniak B, Player MR, Chapman JM, Sowell JW. Azone analogues as penetration enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention. J. Control. Release. 1994;32:147-154.
19. El-Kattan AF, Asbill CS, Michniak BB. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm. 2000;198:179-189.
20. Arellano A, Santoyo S, Martin C, Ygartua P. Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int. J. Pharm. 1996;130:141-145.
21. Williams AC, Barry BW. Terpenes and the lipid protein-partitioning theory of skin penetration enhancement. Pharm. Res. 1991;8:17-24.
22. Cornwell PA, Barry BW, Stoddart CP, Bouwstra JA. Wide-angle x-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment. J. Pharm. Pharmacol. 1994;46:938-950.
23. Berner B, Otte JH, Mazzenga GC, Steffens RJ, Ebert CD. Ethanol: water mutually enhanced transdermal therapeutic system I: Nitroglycerin solution properties and membrane transport. J. Pharm. Sci. 1989;78:314-318.
24. Pershing LK, Lambert LD, Knutson K. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm. Res. 1990;7:170-175.
25. Megrab NA, Williams AC, Barry BW. Estradiol permeation across human skin, silastic and snake skin membranes: effects of ethanol/water co-solvent systems. Int. J. Pharm. 1995;116:101-112.
26. Ghanem AH, Mahmoud H, Higuchi WI, Liu P, Good WR. The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: Methods/validation of a novel approach. Int. J. Pharm. 1992;78:137-156.
27. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int. J. Pharm. 1999;184:1-6.
28. Cornwell PA, Barry BW. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 1994;46:261-269.
29. Ruell JA, Tsinman O, Avdeef A. Acid-base cosolvent method for determining aqueous permeability of amiodarone, itraconazole, tamoxifen, terfenadine and other very insoluble molecules. Chem. Pharm. Bull. 2004;52:561-565.
30. Okabe H, Takayama K, Ogura A, Nagai T. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des. Deliv. 1989;4:313-321.
31. Moghimi HR, Williams AC, Barry BW. Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach. J. Pharm. Pharmacol. 1998;50:955-964.
32. Hori M, Satoch H, Miabach HI, Guy RH. Enhancement effect of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci. 1991;80:32-35.
33. Krishnaiah YSR, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers. J. Control. Release. 2005;106:111-122.
34. Krishnaiah YSR, Bhaskar P, Satyanarayana V. Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic systems for nimodipine. Drug Deliv. 2004;11:1-9.